Insider Shareholders with Direct Ownership of Novavax Inc (NVAX)
This section provides a comprehensive overview of the insiders with direct ownership of Novavax Inc (NVAX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NOVAVAX INC Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Filip Dubovsky
President, R&D |
79,408 | 83,365 | 66,613 $600,183 | 16 |
Jun 17, 2024
Reduced 2.06%
|
112,510 | 52,250 | 61,760 $556,457 | 16 |
Jun 21, 2024
Reduced 10.83%
|
|
10,470 | 24,961 | 50,470 $454,734 | 4 |
Jun 12, 2024
Added 11.67%
|
|
16,420 | 0 | 43,920 $395,719 | 6 |
Jun 12, 2024
Added 13.18%
|
|
John C Jacobs
President and CEO |
83,197 | 40,093 | 43,104 $388,367 | 2 |
Jan 23, 2024
Reduced 48.19%
|
Stanley C Erck
President and CEO |
326,350 | 314,459 | 36,492 $328,792 | 23 |
Dec 14, 2022
Reduced 5.98%
|
John Trizzino
EVP, CCO and CBO |
156,423 | 151,589 | 28,310 $255,073 | 60 |
Aug 19, 2024
Reduced 1.11%
|
Gary C Evans
Director |
27,950 | 24,500 | 19,549 $176,136 | 3 |
Jun 17, 2021
Added 15.0%
|
18,070 | 0 | 18,920 $170,469 | 5 |
Jun 12, 2024
Added 26.06%
|
|
Gregory M Glenn
President, R&D |
213,538 | 219,947 | 18,339 $165,234 | 68 |
Mar 10, 2023
Reduced 11.71%
|
James Patrick Kelly
EVP, CFO and Treasurer |
28,541 | 14,112 | 14,429 $130,005 | 12 |
Aug 16, 2024
Reduced 7.81%
|
Elaine O'Hara
EVP, Chief Strategy Officer |
19,600 | 5,375 | 14,225 $128,167 | 2 |
Mar 01, 2024
Reduced 27.42%
|
John A Herrmann Iii
EVP, Chief Legal Officer |
123,498 | 128,562 | 13,233 $119,229 | 53 |
Dec 14, 2023
Reduced 5.02%
|
10,470 | 0 | 10,470 $94,334 | 2 |
Jun 12, 2024
Added 38.91%
|
|
10,470 | 0 | 10,470 $94,334 | 3 |
Jun 12, 2024
Added 38.91%
|
|
10,470 | 0 | 10,470 $94,334 | 3 |
Jun 12, 2024
Added 38.91%
|
|
Michael A Mcmanus Jr
Director |
7,600 | 4,000 | 10,101 $91,010 | 3 |
Jun 16, 2022
Added 6.48%
|